Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.kashyaptele-medicines.com | |
Market Cap | 9.97 Cr. | |
Enterprise Value(EV) | 9.97 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.37 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 25.32 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 0.14 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 14.83 | Calculated using Price: 2.09 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.77 Cr. | 47,722,000 Shares |
FaceValue | 1 | |
Company Profile | ||
Kashyap Tele-Medicines was incorporated on February 20, 1995 and is based in Ahmedabad. It is one of the leading internet service providers (ISPs) in Gujarat. The company provides value-enhanced technical solutions and professional expertise through a host of services like customized internet and extranet solutions, software application development and networking solutions and services. It specializes in developing custom-made software solutions and services in customer relation management and supply chain management. Services include web-enabled services, data conversion, import and export; end-to-end networking solutions to the end user; and cutting-edge software solutions in mainframe client server and internet environments. The company is mainly engaged in corporate loans, advances & dealing in shares & securities, providing internet services & other allied services. |
1 Day |
|
|
1 Week |
|
-0.48% |
1 Month |
|
-1.42% |
3 Month |
|
+40.27% |
6 Month |
|
-22.30% |
1 Year |
|
+207.35% |
2 Year |
|
+207.35% |
5 Year |
|
+207.35% |
10 Year |
|
+397.62% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 1.04 | 1.44 | 1.14 | 1.73 | 1.76 | 0.98 | 0.56 | 0.46 | -112.89 | |
Return on Capital Employed (%) | 0.99 | 1.37 | 1.34 | 2.03 | 2.16 | 1.35 | 0.63 | 0.63 | -112.95 | |
Return on Assets (%) | 0.98 | 1.36 | 1.08 | 1.62 | 1.70 | 0.97 | 0.56 | 0.46 | -112.03 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | |
Non Curr. Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | |
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other Income | |||||||||||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | 0 | 0 | 0 | 0 | |||||||
Exceptional Items | -2 | -2 | |||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -2 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | |||||||||||
Cash Fr. Finan. | |||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 10 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th February 2023 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Submission of Outcome of Board Meeting held on 10th February 2023 wherein Board of Directors has considered and approved inter alia Unaudited Financial Results along with Limited Review Report thereon as received from the Statutory Auditors of the Company for the third quarter and nine months ended 31st December 2022 and other general businesses. |
Fri, 10 Feb 2023
Submission Of Unaudited Financial Results Of The Company And Limited Review Report Thereon For The Third Quarter And Nine Months Ended 31St December 2022 Submission of Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December 2022 prepared in accordance with Companies (Indian Accounting Standards) Rules 2015 (IND-AS) alongwith the Limited Review Report as received from the Statutory Auditors thereupon as duly reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on 10th February 2023. |
Thu, 02 Feb 2023
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday 10Th February 2023 Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve the Unaudited Financial Results of the Company along with Limited Review Report thereon for the Third Quarter ended 31st December 2022 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for quarter ended 31st December 2022. |
Tue, 28 Mar 2023 |
|
|
|
|
|